Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Investor FAQs

1. Where are Newron shares traded?

Newron shares are listed on the SIX Swiss Exchange.

Back to top

2. What is Newron’s ticker symbol?

NWRN

Back to top

3. What is Newron's number of outstanding shares?

6'603'983 (as of April 1st, 2010)

Back to top

4. What is the date of your next Annual General Meeting?

April 1, 2010  at the Company's registered office located in Bresso (MI), via Ludovico Ariosto,21

Back to top

5. Are there any limitations on voting rights for registered shareholders?

No

Back to top

6. When does Newron's fiscal year end?

Newron's fiscal year is the 12-months ending December 31.

Back to top

7. What accounting convention does Newron adhere to?

 IFRS

Back to top

8. How can I get a copy of your Annual Report?

Our Annual Report is now available on this website.

You can also order a printed copy by sending an e-mail to: ir@newron.com

Back to top

9. Can I subscribe to receive your news automatically?

We have a subscription form online in which you can register for news. Each time something new is published on our Investor Relations website you will receive an E-mail alert. Click here to Register for updates

Back to top